Fortis Healthcare Ltd (FORTIS) — Announcement | 1 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Delhi High Court orders forensic audit into promoter shareholding dissipation
💡 Investor Takeaway
The forensic audit is purely investigative with no immediate financial or liability impact on Fortis.

Fortis Healthcare disclosed an August 31, 2026 Delhi High Court order concerning applications by Daiichi Sankyo related to promoter shareholding dissipation and control changes. The court appointed a forensic auditor for a factual inquiry but imposed no liability or penalty on the company. The order stems from cases EX.APPL.(OS) 3764/2022, 1615/2025, and 3763/2022 involving Singh Brothers. Fortis emphasized it was not a party to the dispute and remains focused on operations and governance.

📄 View Original Announcement (PDF)

About Fortis Healthcare Ltd (FORTIS)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹68,550.2 Cr P/E: 65.4 ROE: 10.8% ROCE: 13.3% Div Yield: 0.11%

View full FORTIS stock details →

📡 Get AI alerts when FORTIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FORTIS — Free

📊 More FORTIS filings

See all FORTIS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FORTIS files new disclosures

Track FORTIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FORTIS — Free

Free account · 2 AI queries/day